o Cohort after propensity score matching = 12,840 (7.8% or 4,280 in each of the 3 tx groups) o Well designed observational study; however, limited by the potential for unknown/unexpected confounders and impact of the inclusion/exclusion criteria on the population to which the results apply. o Unknown/unexpected confounders [opioid group potentially sicker than other group (acute care hospital stay 2.4 days vs 1.9; higher comorbidity index 1.7 vs. 1.6; ↑ falls, ↑ osteoporosis, ↑ renal insufficiency, ↑ chronic back pain, ↑ gout; ↑ ACEI, ARBs, BB, surgery; huge difference in baseline characteristics in eTable 1 before propensity score-matched); variance in dose/duration & ASA/OTC analgesic use not factored in. All opioids in one group.]
Baseline population:
o ~ 90% OA, ~ 10% RA; Age mean= 80; 84% ; on an average of 4.7 different drugs; 32% diabetes, 32%
hypertensive, 6% MI, ~7% previous fractures; 24% on a PPI; 1-2% renal insufficiency; co-morbidity index = 1.5 o Note: this population represents a relatively healthy older (80yr) female OA population with <2 co-morbidities. =female AE=adverse event CI=95% confidence interval CV=cardiovascular HR=hazard ratio NNH=number needed to harm (number of patients that need to be treated for 1yr to observe 1 excess adverse event when initiating an opioid vs a NSAID) rx=prescription yr=year
Results: Safety Events Among Propensity

Considerations:
• Very well done observational study; however, potential for unrecognized confounding leaves the results, especially those with more marginal HRs (e.g. CV & mortality) open to question.
• It is quite likely that opioid use in the elderly is associated with increased fracture risk and related morbidity/mortality as well as bowel obstruction. The HR for these outcomes is more convincing.
• The higher CV risk associated with opioids was unexpected and since HR is much smaller (<2), and since opioids are often chosen for those in whom NSAIDs/Coxibs are contraindicated, this result is open to question.
Bottom Line (Opioids relative to NSAIDs & Coxibs):
• Although opioids are sometimes considered "preferred" in elderly patients due to the well recognized GI, CV and renal risks of NSAIDS/Coxibs, opioids do present their own potential array of harms. One should be aware of the increased risk of falls/fractures and bowel obstruction, and carefully weigh this against any potential benefit.
• Opioids may be associated with an increase in CV events and mortality; however, given the limitations of the study and the modest hazard ratios, this may be the result of confounding and not represent true causality.
{Opioids not usually associated with a direct adverse CV event (except for ↑QT interval with methadone). Opioids may be an indirect cause of CV events 2° to other adverse events. NSAIDs appear to ↑ CV events (CV risk: rofecoxib, diclofenac > ibuprofen & celecoxib at low doses > naproxen appears safest). 2,3 Opioid use has been indirectly associated with ↑ mortality and the recent ↑ in opioid utilization has occurred in association with a rise in opioid related deaths observational data . 4 }
• One should not extrapolate the findings of this study to elderly with several (>2) co-morbidities as NSAIDs & Coxibs may still present significant cardiovascular and renal risks relative to opioids.
